Vimian Group AB (publ) (VIMGF) Financials

VIMGF Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 1.3 billion 490.4 million
Dec. 31, 2025 1.3 billion 470.8 million
Sept. 30, 2025 1.3 billion 500.9 million
June 30, 2025 1.3 billion 524.3 million

VIMGF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 22.0 million ?
Dec. 31, 2025 58.6 million ?
Sept. 30, 2025 10.4 million ?
June 30, 2025 22.5 million ?

VIMGF Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 11.0 million
Dec. 31, 2025 22.5 million
Sept. 30, 2025 7.6 million
June 30, 2025 17.1 million

VIMGF Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 57.9 million 264.6 million 13.8 million
Dec. 31, 2025 64.6 million 262.1 million 18.1 million
Sept. 30, 2025 60.2 million 298.1 million 18.8 million
June 30, 2025 79.6 million 327.1 million 19.4 million

VIMGF Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 606.5 million
Dec. 31, 2025 619.8 million
Sept. 30, 2025 618.2 million
June 30, 2025 617.9 million

VIMGF Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 3.8 million - - -
Dec. 31, 2025 6.8 million - - -
Sept. 30, 2025 2.2 million - 52.2 million -
June 30, 2025 3.7 million - - -

VIMGF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 129.9 million 105.0 million
Dec. 31, 2025 127.8 million 41.4 million
Sept. 30, 2025 122.4 million 37.6 million
June 30, 2025 122.9 million 38.0 million

VIMGF

Price: $2.77

52 week price:
2.68
4.50

Earnings Per Share: 0.07 USD

P/E Ratio: 39.57

Exchange: PNK

Sector: Healthcare

Industry: Diagnostics & Research

Market Capitalization: 1.5 billion

Links: